Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV004998234 | SCV005620273 | benign | Autosomal recessive limb-girdle muscular dystrophy | 2025-01-07 | reviewed by expert panel | curation | The NM_213599.3: c.616A>G variant in ANO5 is a missense variant predicted to cause substitution of threonine by alanine at amino acid 206 (p.Thr206Ala). The filtering allele frequency of this variant is 0.02707 (the lower threshold of the 95% CI of 562/250584 African/African American chromosomes in gnomAD v2.1.1), which is higher than the ClinGen LGMD VCEP threshold (>0.003) for BA1 and therefore meets this criterion (BA1). At least one patient who displayed progressive weakness and a possible congenital myopathy has been reported to have this variant (PMID: 25891276); however, PP4 is not applied when BA1 is met. In summary, this variant meets the criteria to be classified as Benign for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): BA1. |
Eurofins Ntd Llc |
RCV000116355 | SCV000338846 | benign | not specified | 2016-01-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000116355 | SCV000525088 | benign | not specified | 2016-05-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000551276 | SCV000645920 | benign | Gnathodiaphyseal dysplasia; Autosomal recessive limb-girdle muscular dystrophy type 2L | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000988502 | SCV001138249 | benign | Gnathodiaphyseal dysplasia | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001103563 | SCV001260336 | benign | ANO5-Related Muscle Diseases | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
Athena Diagnostics | RCV000116355 | SCV001475529 | benign | not specified | 2020-01-22 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000988502 | SCV002539189 | benign | Gnathodiaphyseal dysplasia | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259605 | SCV002539190 | benign | Miyoshi muscular dystrophy 3 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002259604 | SCV002539191 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2L | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002505038 | SCV002794799 | likely benign | Gnathodiaphyseal dysplasia; Autosomal recessive limb-girdle muscular dystrophy type 2L; Miyoshi muscular dystrophy 3 | 2022-02-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003390801 | SCV004129938 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | ANO5: BP4, BS1, BS2 |
Breakthrough Genomics, |
RCV003390801 | SCV005317826 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000116355 | SCV000150278 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Prevention |
RCV004542837 | SCV004773906 | benign | ANO5-related disorder | 2020-10-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |